New study tracks Real-World results for bowel disease drug in china
NCT ID NCT06838845
Summary
This study follows 80 Chinese adults with moderate to severe ulcerative colitis who are already prescribed the drug upadacitinib by their doctor. The goal is to see how well the medication works in real-world use over one year. Researchers will collect routine health data from regular clinic visits, with no extra tests or procedures required from participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
The First Affiliated Hospital, Sun-Yat Sen University /ID# 272997
RECRUITINGGuangzhou, Guangdong, 510080, China
-
The Second Affiliated Hospital Of Zhengzhou University /ID# 274754
RECRUITINGZhengzhou, Henan, 450014, China
-
The Sixth Affiliated Hospital of Sun Yat-sen University /ID# 274753
RECRUITINGGuangzhou, Guangdong, 510655, China
Conditions
Explore the condition pages connected to this study.